HeartSciences Inc.
HSCS
$3.75
$0.3710.95%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.70% | -33.26% | -25.20% | -18.58% | -3.95% |
| Total Depreciation and Amortization | 34.60% | -29.81% | -25.73% | -34.83% | -29.82% |
| Total Amortization of Deferred Charges | 176.06% | 69.88% | 4.58% | -- | 68.73% |
| Total Other Non-Cash Items | -49.98% | -62.48% | -31.94% | 42.24% | 164.01% |
| Change in Net Operating Assets | 202.68% | 140.75% | -550.44% | -290.49% | -871.25% |
| Cash from Operations | -22.12% | -16.43% | -49.41% | -24.57% | -5.14% |
| Capital Expenditure | 95.04% | -123.18% | -237.78% | -481.08% | -252.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.59% | 1.98% | -- | -1,057.14% | -- |
| Cash from Investing | 75.98% | -43.64% | -594.44% | -657.50% | -584.70% |
| Total Debt Issued | 453.65% | 453.65% | 453.65% | -- | -- |
| Total Debt Repaid | 9.40% | 21.26% | 39.98% | 35.34% | 26.77% |
| Issuance of Common Stock | -88.86% | -87.66% | 332.78% | 397.64% | 48.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.57% | -73.97% | 416.21% | 527.18% | 58.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.56% | -187.06% | 232.80% | 201.82% | 458.78% |